BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. (Q39030603)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Helen Rizos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Alexander M Menzies

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Therese Becker

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Richard F. Kefford

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Georgina V. Long

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

13

John F Thompson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

7

Lauren E Haydu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

3

Gulietta M Pupo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

4

Matteo S Carlino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

5

Carina Fung

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

6

Jessica Hyman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

8

Branka Mijatov

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

10

Suzanah C Boyd

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

11

Julie Howle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

12

Robyn Saw

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

24 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

1965-1977

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24463458%20AND%20SRC:MED&resulttype=core&format=json

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

6 March 2020

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE09626

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2010.11.023

An integrated map of genetic variation from 1,092 human genomes

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE11632